Amanote Research

Amanote Research

    RegisterSign In

The Emerging Role of Tacrolimus in Myasthenia Gravis

Therapeutic Advances in Neurological Disorders - United Kingdom
doi 10.1177/1756285615571873
Full Text
Open PDF
Abstract

Available in full text

Categories
NeurologyPharmacology
Date

February 19, 2015

Authors
Jennifer L. CruzMarissa L. WolffAdam J. VandermanJamie N. Brown
Publisher

SAGE Publications


Related search

The Role of Potassium in Myasthenia Gravis

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1940English

Role of Rituximab in Myasthenia Gravis’ Treatment

Journal of Neurology & Stroke
2017English

Autoimmune Myasthenia Gravis: Emerging Clinical and Biological Heterogeneity

The Lancet Neurology
Neurology
2009English

Myasthenia Gravis

CMAJ
Medicine
2018English

Myasthenia Gravis

Postgraduate Medical Journal
Medicine
1965English

Myasthenia Gravis

Seminars in Neurology
Neurology
2016English

Myasthenia Gravis

JAMA - Journal of the American Medical Association
Medicine
2005English

P-Glycoprotein Function in Peripheral Blood Mononuclear Cells of Myasthenia Gravis Patients Treated With Tacrolimus

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2007English

Thymectomy in Myasthenia Gravis

BMJ
1949English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy